Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease

BACKGROUND: Methylxanthines and leukotriene receptor antagonists (LTRA) are not a first-line medical treatment for chronic obstructive pulmonary disease (COPD) but are frequently prescribed despite limited evidence. We aimed to elucidate the real prescribing status and clinical impacts of these agen...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Chron Obstruct Pulmon Dis
Asıl Yazarlar: Lee, Jung-Kyu, Rhee, Chin Kook, Kim, Kyungjoo, Ra, Seung Won, Lee, Jae Ha, Jung, Ki-Suck, Yoo, Kwang Ha, Kim, Yoo-Il, Kim, Deog Kyeom
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove 2019
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6885559/
https://ncbi.nlm.nih.gov/pubmed/31819397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S216326
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller